Your browser doesn't support javascript.
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.
Hammerschmidt, Swantje I; Bosnjak, Berislav; Bernhardt, Günter; Friedrichsen, Michaela; Ravens, Inga; Dopfer-Jablonka, Alexandra; Hoffmann, Markus; Pöhlmann, Stefan; Behrens, Georg M N; Förster, Reinhold.
  • Hammerschmidt SI; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Bosnjak B; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Bernhardt G; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Friedrichsen M; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Ravens I; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Dopfer-Jablonka A; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Hoffmann M; Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Pöhlmann S; Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Behrens GMN; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.
  • Förster R; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Cell Mol Immunol ; 18(10): 2455-2456, 2021 10.
Article in English | MEDLINE | ID: covidwho-1370721
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Female / Humans / Male Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00755-z

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Female / Humans / Male Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00755-z